Drugs for COVID-19

Adults with a body mass index (BMI) between 25 and 29.9 kg/m2 are considered overweight. Those with a BMI ≥30 are considered obese. The initial recommendation for any weight loss effort is to achieve a 5-10% reduction in weight, which has been associated with a reduction in the risk of developing type 2 diabetes, hypertension, and dyslipidemia. Diet, exercise, and behavior modification are the preferred methods for losing weight, but long-term weight maintenance can be difficult. Several drugs and devices are FDA-approved for weight reduction and maintenance of weight loss.

...  Continue reading
Coming Soon
Drugs for Sexually Transmitted Infections
Tenapanor (Ibsrela) for IBS with Constipation
Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy
Daridorexant (Quviviq) for Insomnia